Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jun 12;19(1):123.
doi: 10.1186/s12883-019-1338-y.

Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study

Affiliations
Meta-Analysis

Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study

Akram Sanagoo et al. BMC Neurol. .

Abstract

Background: The neurofibromatoses (NF) are a group of genetic disorders that interfere negatively with the quality of life (QoL) and influence physical, emotional and social statuses. Studying the effects of neurofibromatoses on various aspects of QoL seems important to implement beneficial strategies in increasing the QoL of NF patients. The aim of this study was to review the literature on quality of life in patients with NF and quantitatively evaluate the effects of Neurofibromatosis on various aspects of quality of life by synthesizing available studies.

Methods: This article is written according to the PRISMA checklist. Different databases including PubMed, Scopus, Google scholar and Web of Science were searched to identify studies that examined QoL of patients with neurofibromatosis. The relevant data obtained from these papers were analyzed by a random-effects model. The heterogeneity of studies was calculated using the I2 index and Egger test was used to determine publication bias. The information was analyzed by R and STATA Ver 14.

Results: Twelve studies were selected as eligible for this research and were included in the final analysis. The number of participants in the study was 7314 individuals containing 910 NF patients (642 NF1 and 268 NF2) and 6404 healthy subjects. The mean scores of sub-scales of QoL were significantly lower in NF patients compared with control except for the scale of cohesion. Family and NF patients had lower quality of life in all aspects of QoL than controls. Also, this meta-analysis shows that NF negatively effects on physical function, bodily pain, mental health, social function and general health. Subgroup analysis showed that NF had negative effects on all sub-scales of QoL if the study was conducted in adults and used a SF-36 questionnaire.

Conclusion: This meta-analysis suggests that NF is a broad spectrum disease, affecting physical function, bodily pain, mental health, social function and general health.

Keywords: Meta-analysis; Neurofibromatosis; Quality of life; Schwannomatosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Prisma flow diagram illustrating selection of articles
Fig. 2
Fig. 2
Meta-analysis of the association of Physical function with QoL in NF patients. Square represents effect estimate of individual studies with more than 95% confidence intervals with the size of squares proportional to the weight assigned to the study in the meta-analysis. In this chart, studies are stored in order of the year of publication and author’s names, based on a random effects model
Fig. 3
Fig. 3
Meta-analysis of the association of Role physical with QoL in NF patients. Square represents effect estimate of individual studies with more than 95% confidence intervals with the size of squares proportional to the weight assigned to the study in the meta-analysis. In this chart, studies are stored in order of the year of publication and author’s names, based on a random effects model
Fig. 4
Fig. 4
Meta-analysis of the association of General health with QoL in NF patients based on type of NF(1: NF1, 2:NF2). Square represents effect estimate of individual studies with more than 95% confidence intervals with the size of squares proportional to the weight assigned to the study in the meta-analysis. In this chart, studies are stored in order of the year of publication and author’s names, based on a Random Effects Model
Fig. 5
Fig. 5
Meta-analysis of the association of Bodily pain with QoL in NF patients based on age group. Square represents effect estimate of individual studies with more than 95% confidence intervals with the size of squares proportional to the weight assigned to the study in the meta-analysis. In this chart, studies are stored in order of the year of publication and author’s names, based on a fixed effects model
Fig. 6
Fig. 6
Meta-analysis of the association of General health with QoL in NF patients based on type of questionnaire (1: SF-36, 2: CHQ, 3: ITQOL). Square represents effect estimate of individual studies with more than 95% confidence intervals with the size of squares proportional to the weight assigned to the study in the meta-analysis. In this chart, studies are stored in order of the year of publication and author’s names, based on a Random effects model
Fig. 7
Fig. 7
Begg’s funnel plot for publication bias in the risk difference (RD) analysis. The diameter of each circle represents the weight in the meta-analysis

References

    1. Zale EL, Pierre-Louis C, Macklin EA, Riklin E, Vranceanu AM. The impact of a mind–body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis. J Neuro-Oncol. 2018;137(2):321–329. doi: 10.1007/s11060-017-2720-5. - DOI - PubMed
    1. Ngo-Huang A, Yadav R, Fu JB, Liu D, Williams JL, Bruera E, Guo Y. Mobility functional outcomes of neurofibromatosis patients: a preliminary report. Am J Phys Med Rehabil. 2018;97(1):41–49. doi: 10.1097/PHM.0000000000000842. - DOI - PubMed
    1. Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004. doi: 10.1038/nrdp.2017.4. - DOI - PubMed
    1. Pannu AK, Sharma N. Neurofibromatosis type 1 and disseminated malignant peripheral nerve sheath tumor. QJM. 2017;110(9):583–584. doi: 10.1093/qjmed/hcx071. - DOI - PubMed
    1. Lu-Emerson C, Plotkin SR. The neurofibromatoses. Part 1: NF1. Rev Neurol Dis. 2009;6:47–53. - PubMed